Home › Funds › Integral Health Asset Management, LLC › BSX

Integral Health Asset Management, LLC position in BSX

BOSTON SCIENTIFIC CORP · Health Care

Integral Health Asset Management, LLC reported holding 400,000 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$17.5M, representing 1.13% of its reported portfolio and ranking #28 among its reported holdings. Integral Health Asset Management, LLC has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)400.00K sh
Reported value held$17.46M
Portfolio Weight1.13%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Integral Health Asset Management, LLC's BSX position evolved

Integral Health Asset Management, LLC first disclosed a stake in BSX in Q3 2023 at 550,000 shares (US$29.0M). The position peaked in Q1 2025 at 650,000 shares, worth US$65.6M. Across 13 filings, Integral Health Asset Management, LLC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 400,000 shares valued at US$17.5M — a reduction of -500,000 shares quarter over quarter.. Notable position changes include a 60% increase in Q1 2024 (shares rose 12% over the following quarter), a 144% increase in Q1 2026 (shares fell 32% over the following quarter), a 64% increase in Q2 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 550.00K $29.04M New
Q4 2023 375.00K $21.68M Reduce
Q1 2024 600.00K $41.09M Add
Q2 2024 650.00K $50.06M Add
Q3 2024 550.00K $46.09M Reduce
Q4 2024 550.00K $49.13M Hold
Q1 2025 650.00K $65.57M Add
Q2 2025 550.00K $59.08M Reduce
Q3 2025 300.00K $29.29M Reduce
Q4 2025 225.00K $21.45M Reduce
Q1 2026 550.00K $34.51M Add
Q2 2026 900.00K $38.41M Add
Q3 2026 400.00K $17.46M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), Arrowstreet Capital (US$1.24B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has Integral Health Asset Management, LLC held BSX?

Integral Health Asset Management, LLC has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Integral Health Asset Management, LLC's current position in BSX?

As of Q3 2026, Integral Health Asset Management, LLC holds 400.00K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $17.46M, representing 1.13% of its reported portfolio and ranking #28.

Has Integral Health Asset Management, LLC been buying or selling BSX?

In the latest 13F filing (Q3 2026), Integral Health Asset Management, LLC reduced its position in BSX. The position peaked in Q1 2025 at 650.00K shares.

Which other funds hold BSX?

Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, Arrowstreet Capital, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.